The impact of COVID-19 on breast cancer screening, treatment, research and meetings
The impact of COVID-19 on breast cancer screening, treatment, research and meetings
Improved decision making for older women with early breast cancer
MINDACT: 70-gene signature test as guidance for breast cancer treatment
OS results from SOLAR-1: Alpelisib plus fulvestrant for HR positive, HER2 negative advanced breast cancer
OncoAlert and ecancer weekly roundup for September 20 - 26, 2020
Highlights from ESMO 2020
ASCENT: Sacituzumab govitecan vs treatment of physician’s choice in patients with previously treated mTNBC
Breast cancer roundup from ESMO 2020
OncoAlert and ecancer weekly roundup for September 14-19, 2020
IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer
MonarchE: Abemaciclib plus endocrine therapy in high-risk early breast cancer
BOUNCE project: Studying patient resilience in breast cancer